Gemini 3 has left all its competitors behind. It’s Google’s definitive punch to the table: Crossover 1×32

Three years ago, panic on Google. The launch of ChatGPT made Google will declare a “code red” before an AI model that proposed a clear revolution and a clear threat to the search business. Sundar Pichai began to make moves, but the truth is that the first movements with Bard They were disastrous. There were more problems and blundersbut since then Google’s trajectory has been spectacular, and its AI models have not stopped achieving success. We saw it with Gemini 2.5 Pro and with Nano Bananabut now they have proven it again with Gemini 3which has managed to become the model with the best features in most areas, at least according to the benchmarks offered by the company. It is somewhat surprising, especially considering that OpenAI seemed to have controlled the market with a ChatGPT that continues to be more popular but is little by little being cornered by the competition. In fact Google seems to be doing everything right lately in this area. DeepMind is the great reference for “serious AI”and Google’s enormous resources—which has its own cloud, its own chips, and its own model—point to a bright future for this company. We talk about all of this precisely in this episode Crossover 1×32 in which we review those hesitant beginnings of Google and how the company has managed to get rid of its fears to bet everything on AI. That in itself is surprising, because that bet is also risky for them. Exciting times! On YouTube | Crossover

20 years after Dolly we still haven’t cloned humans, but stopping aging is feasible: Crossover 1×32

In the summer of 1996, a Scottish laboratory made a breakthrough that would forever alter our understanding of genetics and ignite intense debates about the ethics and the possibilities of cloning. That day Dolly was bornthe first mammal cloned from an adult somatic cell. This milestone, achieved by researchers at the Roslin Institute, opened a new era in genetic engineering and shattered the belief that only embryonic cells possess the potential for the complete development of a new individual. Since then there has been debate about the possibility of cloning human beings, but we have not done it and it does not seem that we will ever do it. Serezade, molecular biologist, researcher and scientific communicator, talks to us about that and many other things this week. But we also discussed with her another fascinating topic: how the latest advances seem to be achieving something long sought after: slow aging. There is a lot of fabric to cut here, and for example the environment, culture and habits shape our DNA. But there are also risks, ethics and genetic privacy intertwined. And all this raises a key question: does it make sense to be immortal? On YouTube | Crossover In Xataka | The promise of 120 years is dismantled: biology sets a life ceiling that is quite difficult to break

Log In

Forgot password?

Forgot password?

Enter your account data and we will send you a link to reset your password.

Your password reset link appears to be invalid or expired.

Log in

Privacy Policy

Add to Collection

No Collections

Here you'll find all collections you've created before.